Singular Genomics Systems, Inc. (OMIC)
USD 19.6
(-0.56%)
USD 19.6
(-0.56%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -102.8 Million USD | -9.96% |
| 2022 | -93.48 Million USD | -52.56% |
| 2021 | -61.27 Million USD | -122.56% |
| 2020 | -27.53 Million USD | -115.61% |
| 2019 | -12.77 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -22.8 Million USD | 15.06% |
| 2024 Q1 | -26.84 Million USD | -6.2% |
| 2023 Q3 | -24.53 Million USD | 11.1% |
| 2023 FY | -102.8 Million USD | -9.96% |
| 2023 Q4 | -25.28 Million USD | -3.02% |
| 2023 Q2 | -27.6 Million USD | -8.77% |
| 2023 Q1 | -25.37 Million USD | -12.64% |
| 2022 Q2 | -24.24 Million USD | -10.1% |
| 2022 Q1 | -22.02 Million USD | -11.93% |
| 2022 FY | -93.48 Million USD | -52.56% |
| 2022 Q4 | -22.53 Million USD | 8.76% |
| 2022 Q3 | -24.69 Million USD | -1.86% |
| 2021 FY | -61.27 Million USD | -122.56% |
| 2021 Q4 | -19.67 Million USD | -12.67% |
| 2021 Q3 | -17.46 Million USD | -25.77% |
| 2021 Q1 | -10.26 Million USD | -35.29% |
| 2021 Q2 | -13.88 Million USD | -35.29% |
| 2020 FY | -27.53 Million USD | -115.61% |
| 2020 Q4 | -7.58 Million USD | 2.48% |
| 2020 Q3 | -7.77 Million USD | -14.92% |
| 2020 Q2 | -6.76 Million USD | -25.26% |
| 2020 Q1 | -5.4 Million USD | 0.0% |
| 2019 FY | -12.77 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | -78.264% |
| AngioDynamics, Inc. | -97.71 Million USD | -5.202% |
| AtriCure, Inc. | -26.68 Million USD | -285.268% |
| Avinger, Inc. | -16.63 Million USD | -517.98% |
| Azenta, Inc. | -73.12 Million USD | -40.581% |
| BioLife Solutions, Inc. | -70.82 Million USD | -45.148% |
| The Cooper Companies, Inc. | 533.1 Million USD | 119.284% |
| Daxor Corporation | -177.07 Thousand USD | -57955.061% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | -580.261% |
| Femasys Inc. | -14.5 Million USD | -608.561% |
| GlucoTrack, Inc. | -7.1 Million USD | -1347.086% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 5527.719% |
| Hologic, Inc. | 882.6 Million USD | 111.648% |
| ICU Medical, Inc. | 22.82 Million USD | 550.388% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 105.818% |
| KORU Medical Systems, Inc. | -10.26 Million USD | -900.985% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 377.226% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -1389.753% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -1389.753% |
| Masimo Corporation | 136.5 Million USD | 175.312% |
| Microbot Medical Inc. | -9.85 Million USD | -943.135% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 800.521% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 182.941% |
| Nephros, Inc. | -1.59 Million USD | -6353.296% |
| NovoCure Limited | -232.87 Million USD | 55.855% |
| NEXGEL, Inc. | -3.47 Million USD | -2856.601% |
| NEXGEL, Inc. | -3.47 Million USD | -2856.601% |
| OraSure Technologies, Inc. | 54.07 Million USD | 290.094% |
| Pro-Dex, Inc. | 7.17 Million USD | 1533.166% |
| Pulse Biosciences, Inc. | -43.57 Million USD | -135.923% |
| Predictive Oncology Inc. | -13.92 Million USD | -638.442% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -3673.437% |
| QuidelOrtho Corporation | 139.1 Million USD | 173.904% |
| Repligen Corporation | 54.57 Million USD | 288.363% |
| Sanara MedTech Inc. | -4.21 Million USD | -2338.844% |
| STAAR Surgical Company | 28.09 Million USD | 465.879% |
| Sharps Technology, Inc. | -10.12 Million USD | -915.153% |
| Utah Medical Products, Inc. | 16.77 Million USD | 712.75% |
| DENTSPLY SIRONA Inc. | -85 Million USD | -20.942% |
| Jin Medical International Ltd. | 2.86 Million USD | 3685.337% |